Form 4: RadNet CEO Howard Berger Acquires Shares and Options Following RSU Vesting

Howard Berger, CEO of RadNet, Inc., reports acquisition of shares and options due to the vesting of restricted stock units (RSUs) based on the company's 2023 performance.

Summary

• On March 1, 2024, Howard Berger, the President and CEO of RadNet, Inc., reported transactions involving RadNet's common stock and employee stock options.
• These transactions are related to the vesting of restricted stock units (RSUs) and stock options granted on January 3, 2023.
• The vesting was determined by the Compensation Committee based on RadNet's fiscal year 2023 performance.
• 40,236 shares vested due to the performance-based vesting requirements of the RSUs.
• These RSUs will vest in two equal annual installments on March 10, 2025, and March 10, 2026, subject to continued service.
• Additionally, 77,976 shares underlying stock options vested due to performance-based requirements.
• These option shares will vest in three equal annual installments on March 10, 2025, March 10, 2026, and March 10, 2027, subject to continued service.
• The exercise price of the stock options is $18.64.
• The vested RSUs represent the contingent right to receive one share of RDNT common stock and will be settled upon separation from service, death, disability, a change in control, or a future deferral election date.

Sentiment

Score: 7

Explanation: The document reflects standard executive compensation practices and positive company performance, leading to the vesting of RSUs and stock options. This suggests a stable and incentivized management team.

Positives

• The vesting of RSUs and stock options indicates that RadNet's Compensation Committee assessed the company's fiscal year 2023 performance positively.
• The CEO's increased stake in the company aligns his interests with those of shareholders.

Future Outlook

The RSUs and stock options will continue to vest in future years, contingent upon the reporting person's continued service.

Management Comments

• The Compensation Committee determined that 200% of the target number of RSUs vested based on the Issuer's fiscal year 2023 performance.
• 100% of the shares subject to the option vested as to the performance-based vesting requirements as a result of the Issuer's performance for fiscal year 2023.

Industry Context

Vesting of stock options and RSUs are common practices in publicly traded companies to incentivize and retain key executives. The specific vesting terms are tailored to the company's performance and strategic goals.

Comparison to Industry Standards

• RadNet's use of RSUs and stock options for executive compensation aligns with industry practices among publicly traded healthcare companies.
• Companies like HCA Healthcare and Universal Health Services also utilize similar equity-based compensation plans to incentivize performance and retain key personnel.
• The vesting schedules and performance metrics associated with these grants are typically benchmarked against industry peers to ensure competitiveness and alignment with shareholder value creation.

Stakeholder Impact

• The vesting of RSUs and stock options aligns management's interests with those of shareholders, potentially driving long-term value creation.
• Employees may view the vesting as a positive sign of company performance and stability.

Next Steps

• The reporting person will continue to hold and potentially exercise the vested stock options.
• The remaining RSUs and stock options will vest in subsequent years based on continued service.

Key Dates